Clik here to view.
ヘンリーシャインとヴェッツ・ファースト・チョイスが予定している新会社の名称を発表：Covetrus
米ニューヨーク州メルビル & メーン州ポートランド （ビジネスワイヤ） — ヘンリーシャイン（Nasdaq: HSIC）とヴェッツ・ファースト・チョイスは本日、ヘンリーシャインの動物医療事業部のスピンオフとその後のヴェッツ・ファースト・チョイスとの合併によって生まれる新たな独立した公開会社の名称がCovetrusになると発表しました。...
View ArticleClik here to view.
汉瑞祥和Vets First Choice宣布，依计划产生的新公司命名为Covetrus
纽约州梅尔维尔和缅因州波特兰 (美国商业资讯)–汉瑞祥公司(Henry Schein, Inc.; Nasdaq: HSIC)和Vets First Choice今天宣布，依计划从Henry Schein Animal Health业务分拆并随后与Vets First Choice合并而产生的新的独立上市公司将命名为Covetrus。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
VivaGel® Condom Receives Final Regulatory Approval in Japan
MELBOURNE, Australia Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that the VivaGel® condom has received final regulatory approval and is now able to be marketed in Japan, following the...
View ArticleClik here to view.
Gynesonics Announces $75 Million Financing
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company and the developer of the Sonata System and other advanced, incision-free solutions for the treatment of uterine conditions, today...
View ArticleClik here to view.
Takeda Announces Multiple Cell Therapy Collaborations to Advance the...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502) today announced new research collaborations in immuno-oncology (I-O), an area of key strategic focus...
View ArticleClik here to view.
武田宣布多项细胞疗法合作，以推进公司的新型免疫肿瘤学阵容
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社（“武田”）(TSE: 4502)今天宣布新的免疫肿瘤学(I-O)研究合作，这是该公司关键战略重点领域。通过上述合作，武田寻求加快发现下一代癌症免疫治疗药物，包括新型细胞疗法，该方法有望为满足难治性癌症患者需求提供重要机遇。 武田肿瘤治疗领域部主管Phil Rowlands,...
View ArticleClik here to view.
武田薬品、新規がん免疫療法ポートフォリオの拡充に向け、細胞療法での複数社との協業を発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（武田薬品）（TSE: 4502）は本日、当社が戦略的に特に重視しているがん免疫療法の領域での新たな研究協業を発表しました。これらの協業を通じて、武田薬品は治療が困難ながん患者のニーズに応える上で重要な機会となり得る新規の細胞療法の手法を含め、次世代のがん免疫療法薬の創薬を促進します。...
View ArticleClik here to view.
Samsung Bioepis Partners with 3SBio to Expand Biosimilar Business into China
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that its rapidly growing biosimilar business will expand into mainland China through a licensing agreement with 3SBio Inc. The agreement...
View ArticleClik here to view.
Factory CRO and Boston Biomedical Associates Announce Merger
BILTHOVEN, Netherlands & MARLBOROUGH, Mass. Factory-CRO Group, a leading global contract research organization (CRO) focused on medical devices and in vitro diagnostics (IVDs), and Boston...
View ArticleClik here to view.
Lift Brands Evolves Strategic Direction with New Leadership
CHANHASSEN, Minn. Peter Taunton, founder and CEO of Lift Brands, announced that effective Jan. 1, 2019 he will transition to non-executive chairman of the Lift Brands board, a strategic advisory...
View ArticleClik here to view.
CANbridge Pharmaceuticals and WuXi Biologics Expand Rare Disease Therapeutics...
BEIJING CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved medical conditions in China and other markets, and WuXi Biologics...
View ArticleClik here to view.
Factory CRO与Boston Biomedical Associates宣布合并
荷兰比尔特霍芬和马萨诸塞州马尔堡 (美国商业资讯) — Factory-CRO Group与Boston Biomedical Associates (BBA)宣布两家组织合并，前者是全球领先的合同研究组织(CRO)，专攻医疗器械及体外诊断(IVD)，而BBA是提供医疗器械/生物技术优质全方位服务的CRO和咨询公司，总部位于美国。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
P&G: Pantene Japan Launched the Advertising Campaign “#HairWeGo My Hair Moves...
KOBE, Japan Pantene Japan (Headquarters: Kobe City) launched the adverting campaign “#HairWeGo My Hair Moves Me Forward” in the Japanese national newspaper “Asahi Shimbun” on January 7th, 2019...
View ArticleClik here to view.
Mobi来了：瑞思迈首款便携式制氧设备现在美国全面上市
圣迭戈 (美国商业资讯) — 呼吸医护医疗器械和院外医护软件的领先者瑞思迈(ResMed, NYSE: RMD, ASX: RMD)今天宣布，其精品级便携式氧浓缩仪Mobi现已在美国全面上市。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20190109005749/zh-CN/ ResMed Mobi...
View ArticleClik here to view.
Clik here to view.
研发型生物制药行业采用新的行业准则以提高全球商业诚信度
日内瓦 (美国商业资讯)—国际药品制造商和协会联合会(IFPMA)新的行业准则已于2019年1月1日生效。2019版的“准则”有两大重要变化。第一，IFPMA成员公司无论在何处经营，一律禁止为处方药品提供礼品和赠品（所谓的“好处”）。第二，从基于规则的方式变为基于价值的准则，以期更好地指导IFPMA成员与医疗保健社区之间的商业行为和互动。...
View ArticleClik here to view.
Gynesonics Announces Publication of Final SONATA IDE Pivotal Trial Results in...
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company and the developer of the Sonata® system for the treatment of uterine fibroids (also known as leiomyomas) today announced the publication...
View ArticleClik here to view.
LifeMap Sciences, Tianjin Novogene and Shanghai Shanyi Announce Strategic...
ALAMEDA, Calif. LifeMap Sciences, Inc., a subsidiary of AgeX Therapeutics, Inc. (NYSE American: AGE) announced today that Tianjin Novogene Medical Laboratory, LifeMap, and Shanghai Shanyi today...
View ArticleClik here to view.
LP3 Network推出面向激素健康执业者的全方位网上学习课程
佛罗里达州阿文图拉 (美国商业资讯) — 鉴于继续教育对激素健康的根本性价值，LP3 Network欣然宣布与激素健康研究所(Institute for Hormonal Health™, IHH)缔结新的伙伴关系，担任面向激素健康的综合性方法IHH教育课程(IHH Educational Program™)的全球独家经销商！ IHH首席医学官Kristy Prouse, MD, FRCSC...
View ArticleClik here to view.
韩国食品品牌Nature Food将’钟根堂6年根金牌红参’产品推向海外市场
韩国首尔 (美国商业资讯)–Ewha Company(www.ewhacompany.com)的食品品牌Nature Food正式着手保健食品’钟根堂6年根金牌红参’的海外推广。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20190110005202/zh-CN/ 钟根堂6年根金牌红参. Ewha...
View Article